AIM ImmunoTech's total assets for Q3 2025 were $5.49M, an increase of 33.06% from the previous quarter. AIM total liabilities were $11.57M for the fiscal quarter, a 8.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.